C4 Therapeutics, Inc.: cashflow_financing

Value{"amount": 34583000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Period2024-01-01 – 2024-03-31
Statuscurrent
EntityC4 Therapeutics, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001628280-24-021368
Retrieved: 2026-08-19T17:06:02.697479+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001662579/cashflow-financing/2024-03-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/317a0afc-4e96-4e79-b8b7-fc5cb430fe00

History